|
12
|
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
PAR-25-256 · National Institutes of Health · basic research
|
biomedical clinical
ai data science
public health
|
— |
2024-11-15 |
2027-01-07 |
63 |
|
8
|
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
PAR-25-069 · National Institutes of Health · basic research
|
biomedical clinical
public health
ai data science
|
— |
2024-11-18 |
2027-01-07 |
63 |
|
8
|
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
PAR-25-070 · National Institutes of Health · basic research
|
biomedical clinical
public health
|
— |
2024-11-18 |
2027-01-07 |
63 |
|
8
|
High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)
RFA-DA-25-024 · National Institutes of Health · basic research
|
biomedical clinical
public health
mental behavioral health
|
— |
2024-08-02 |
2027-03-06 |
121 |
|
5
|
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
PAR-25-081 · National Institutes of Health · basic research
|
biomedical clinical
public health
computing communications
|
$499,999 |
2024-11-12 |
2027-01-07 |
63 |
|
5
|
NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed)
PAR-24-269 · National Institutes of Health · basic research
|
biomedical clinical
mental behavioral health
ai data science
|
— |
2024-08-13 |
2027-02-11 |
98 |